Comparative Study of JTT-751 with Sevelamer hydrochloride in Hemodialysis Patients

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221394

Enrollment

200

Registered

2011-03-07

Start date

2011-03-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Interventions

investigational material(s) Generic name etc : JTT-751 INN of investigational material : Therapeutic category code : 219 Other cardiovascular agents Dosage and Administration for Investigational mate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing hemodialysis 3 times weekly

Exclusion criteria

Exclusion criteria: Patients with gastrointestinal diseases, such as peptic ulcer Patients with advanced cardiac disease, or with hepatic dysfunction

Design outcomes

Primary

Measure	Time frame
The change in serum P levels	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026